BIOEMTECH participated in EMIM 2026, held in Ljubljana, Slovenia, from March 24 to 27.
As part of the scientific program, our team presented three posters covering different aspects of preclinical molecular imaging, including tumor metabolism, radiopharmaceutical imaging, and quantitative analysis. In addition, a collaborating research group (LBMI at FORTH-IESL) presented results generated using the φ-eye™ system, further contributing to the scientific exchange.
Through its participation at EMIM 2026, BIOEMTECH continues to support the development of reliable and accessible tools for preclinical imaging, contributing to the advancement of radiopharmaceutical research.